
![]() |
|
John P. Lynch, M.D. Associate Professor of Medicine
CONTACT INFORMATION
Washington University School of Medicine EDUCATION/TRAINING
Under-Graduate Education: Graduate Education: Residency (Internal Medicine): Fellowship (Pulmonary Disease and Critical Care Medicine): POSITIONS
Washington University School of Medicine, St. Louis, MO PUBLICATIONS
Books Lynch JP, Trulock EP, Cooper JD. The perioperative care of lung transplant recipients. Eds. Bone RC, Dantzker DR, George RB, Matthay RA, Reynolds HY. Pulmonary and Critical Care Medicine. Chicago: Mosby-Year Book, Inc, 1998 Journal Articles Paranjothi S, Yusen RD, Kraus MD, Lynch JP, Patterson GA, Trulock EP. Lymphoproliferative disease after lung transplantation: Comparison of presentation and outcome of early and late cases. J Heart Lung Transplant 2001; 20:1054-1063 Sanchez JL, Kruger RM, Paranjothi S, Trulock EP, Lynch JP, Hicks C, Shannon WD, Storch GA. Relationship of cytomegalovirus viral load in blood to pneumonitis in lung transplant recipients. Transplantation 2001; 72:733-735 Rizzo M, SivaSai KS, Smith MA, Trulock EP, Lynch JP, Patterson GA, Mohanakumar T. Increased expression of inflammatory cytokines and adhesion molecules by alveolar macrophages of human lung allograft recipients with acute rejection: Decline with resolution of rejection. J Heart Lung Transplant 2000; 19:858-865 Meyers BF, Lynch JP, Battafarano RJ, Guthrie TJ, Trulock EP, Cooper JD, Patterson GA. Lung transplantation is warranted for stable, ventilator-dependent recipients. Ann Thorac Surg 2000; 70:1675-1678 Lynch JP, Forman SA, Graff SI, Gunby MC. High-risk population health management – achieving improved patient outcomes and near-term financial results. The American J Managed Care 2000; 6(7):781-791, 31-41 Vizza CD, Yusen RD, Lynch JP, Fedele F, Patterson GA, Trulock EP. Outcome of patients with cystic fibrosis awaiting lung transplantation. 2000, In Press Meyers BF, Lynch JP, Trulock EP, Guthrie T, Cooper JD, Patterson GA. Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis: A ten-year institutional experience. J Thorac Cardiovasc Surg 2000; 120:99-107 SivaSai KSR, Smith MA, Poindexter NJ, Sundaresan SR, Trulock EP, Lynch JP, Cooper JD, Patterson GA, Mohanakumar T. Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans dyndrome. Transplantation 1999; 67:1094-1094 Jaramillo A, Smith MA, Phelan D, Sundaresan S, Trulock EP, Lynch JP, Cooper JD, Patterson GA, Mohankumar T. Development of Eliza-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplantation 1999; 67:1155-1161 Kruger RM, Shannon WD, Arens MQ, Lynch JP, Storch GA, Trulock EP. The impact of Gancyclovir-resistant cytomegalovirus infection after lung transplantation. Transplantation 1999; Vol 68:1272-1279, No. 9 Meyers BF, Lynch JP, Trulock EP, Guthrie TJ, Cooper JD, Patterson GA. Lung transplantation: A decade of experience. Annals of Surgery 1999; 230:362-371 Calhoun R, SivaSai KSR, Sundaresan S, Trulock EP, Lynch JP, Patterson GA, Cooper JD, Mohanakumar T. Development of bronchiolitis obliterans syndrome despite blood chimerism in human lung transplant recipients. Transpl Int 1999; 12:439-446
Division of Pulmonary and Critical Care Medicine
|